Literature DB >> 19842016

Supercritical phase inversion of starch-poly(epsilon-caprolactone) for tissue engineering applications.

Ana Rita C Duarte1, João F Mano, Rui L Reis.   

Abstract

In this work, a starch-based polymer, namely a blend of starch-poly(epsilon-caprolactone) was processed by supercritical assisted phase inversion process. This processing technique has been proposed for the development of 3D structures with potential applications in tissue engineering applications, as scaffolds. The use of carbon dioxide as non-solvent in the phase inversion process leads to the formation of a porous and interconnected structure, dry and free of any residual solvent. Different processing conditions such as pressure (from 80 up to 150 bar) and temperature (45 and 55 degrees C) were studied and the effect on the morphological features of the scaffolds was evaluated by scanning electron microscopy and micro-computed tomography. The mechanical properties of the SPCL scaffolds prepared were also studied. Additionally, in this work, the in vitro biological performance of the scaffolds was studied. Cell adhesion and morphology, viability and proliferation was assessed and the results suggest that the materials prepared are allow cell attachment and promote cell proliferation having thus potential to be used in some for biomedical applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19842016     DOI: 10.1007/s10856-009-3909-8

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  23 in total

Review 1.  Scaffold design and fabrication technologies for engineering tissues--state of the art and future perspectives.

Authors:  D W Hutmacher
Journal:  J Biomater Sci Polym Ed       Date:  2001       Impact factor: 3.517

2.  Optimization of the formulation and mechanical properties of starch based partially degradable bone cements.

Authors:  Luciano F Boesel; João F Mano; Rui L Reis
Journal:  J Mater Sci Mater Med       Date:  2004-01       Impact factor: 3.896

Review 3.  Polymeric scaffolds for bone tissue engineering.

Authors:  Xiaohua Liu; Peter X Ma
Journal:  Ann Biomed Eng       Date:  2004-03       Impact factor: 3.934

4.  In vivo response to starch-based scaffolds designed for bone tissue engineering applications.

Authors:  A J Salgado; O P Coutinho; R L Reis; J E Davies
Journal:  J Biomed Mater Res A       Date:  2007-03-15       Impact factor: 4.396

Review 5.  Functional electrospun nanofibrous scaffolds for biomedical applications.

Authors:  Dehai Liang; Benjamin S Hsiao; Benjamin Chu
Journal:  Adv Drug Deliv Rev       Date:  2007-08-25       Impact factor: 15.470

Review 6.  Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends.

Authors:  J F Mano; G A Silva; H S Azevedo; P B Malafaya; R A Sousa; S S Silva; L F Boesel; J M Oliveira; T C Santos; A P Marques; N M Neves; R L Reis
Journal:  J R Soc Interface       Date:  2007-12-22       Impact factor: 4.118

7.  Development of porous lamellar poly(L-lactic acid) scaffolds by conventional injection molding process.

Authors:  Satyabrata Ghosh; Júlio C Viana; Rui L Reis; João F Mano
Journal:  Acta Biomater       Date:  2008-03-18       Impact factor: 8.947

8.  Porous starch-based drug delivery systems processed by a microwave route.

Authors:  P B Malafaya; C Elvira; A Gallardo; J San Román; R L Reis
Journal:  J Biomater Sci Polym Ed       Date:  2001       Impact factor: 3.517

9.  Starch-poly(epsilon-caprolactone) and starch-poly(lactic acid) fibre-mesh scaffolds for bone tissue engineering applications: structure, mechanical properties and degradation behaviour.

Authors:  M E Gomes; H S Azevedo; A R Moreira; V Ellä; M Kellomäki; R L Reis
Journal:  J Tissue Eng Regen Med       Date:  2008-07       Impact factor: 3.963

10.  Fabrication of HA/PHBV composite scaffolds through the emulsion freezing/freeze-drying process and characterisation of the scaffolds.

Authors:  Naznin Sultana; Min Wang
Journal:  J Mater Sci Mater Med       Date:  2007-08-01       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.